Cargando…

Dilated cardiomyopathy: antifibrotic effect of IGF1

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Company of Biologists Limited 2012
Materias:	In this Issue
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3380699/

Ejemplares similares

Heart-specific deletion of CENP-F causes dilated cardiomyopathy
Publicado: (2012)

Involvement of hepatic macrophages in the antifibrotic effect of IGF-I-overexpressing mesenchymal stromal cells
por: Fiore, Esteban, et al.
Publicado: (2016)

Regulating IGF1 bioavailability is crucial for normal development
Publicado: (2011)

Dilated cardiomyopathy
por: Schultheiss, Heinz-Peter, et al.
Publicado: (2019)

Shared Genetic Etiology of Primary Dilated Cardiomyopathy and Ischemic Dilated Cardiomyopathy
por: Sun, Yang, et al.
Publicado: (2021)

Antifibrotics in India
por: Dhar, Raja
Publicado: (2019)

Dilated cardiomyopathies and non-compaction cardiomyopathy
por: Hänselmann, A., et al.
Publicado: (2020)

Cardiomyopathy, familial dilated
por: Taylor, Matthew RG, et al.
Publicado: (2006)

Dilated cardiomyopathy in childhood
por: Franklin, OM, et al.
Publicado: (2000)

Immunoadsorption in dilated cardiomyopathy
por: Wakabayashi, Y, et al.
Publicado: (2009)

Apoptosis in Dilated Cardiomyopathy
por: Hong, Bum Kee, et al.
Publicado: (2000)

Speckle tracking echocardiography in hypokinetic non‐dilated cardiomyopathy: comparison with dilated cardiomyopathy
por: Mombeini, Hoda, et al.
Publicado: (2020)

Peripartum cardiomyopathy and dilated cardiomyopathy: different at heart
por: Bollen, Ilse A. E., et al.
Publicado: (2015)

The Elusive Antifibrotic Macrophage
por: Adhyatmika, Adhyatmika, et al.
Publicado: (2015)

Significance of myocardial tenascin‐C expression in left ventricular remodelling and long‐term outcome in patients with dilated cardiomyopathy
por: Yokokawa, Tetsuro, et al.
Publicado: (2016)

How hypertrophic cardiomyopathy manifests: clues from development
Publicado: (2011)

Effects of stem cell therapy on dilated cardiomyopathy
por: Jiao, Rong, et al.
Publicado: (2014)

Effect of cardiac resynchronisation therapy in dilated cardiomyopathy
por: Bouwmeester, S., et al.
Publicado: (2021)

The Mutations Associated with Dilated Cardiomyopathy
por: Parvari, Ruti, et al.
Publicado: (2012)

Hypoparathyroidism and reversible dilated cardiomyopathy
por: Babu, M. Suresh, et al.
Publicado: (2011)

Calreticulin Induces Dilated Cardiomyopathy
por: Lee, Dukgyu, et al.
Publicado: (2013)

Infants with dilated cardiomyopathy and hypocalcemia
por: Sanyal, Debmalya, et al.
Publicado: (2013)

LMNA-related dilated cardiomyopathy
por: Vaikhanskaya, Tatiyana, et al.
Publicado: (2014)

Rhinovirus-associated dilated cardiomyopathy
por: Chow, Jeffrey, et al.
Publicado: (2020)

Myocarditis and idiopathic dilated cardiomyopathy
por: Brown, Charles A., et al.
Publicado: (1995)

Echocardiographic Advances in Dilated Cardiomyopathy
por: Faggiano, Andrea, et al.
Publicado: (2021)

Transcriptomics and Beyond in Dilated Cardiomyopathy
por: Cowan, Jason R., et al.
Publicado: (2023)

The Genetic Evaluation of Dilated Cardiomyopathy
por: Bui, Quan M., et al.
Publicado: (2023)

Cushing Syndrome in the Setting of Chronic Dilated Cardiomyopathy: Can Treatment Improve Chronic Dilated Cardiomyopathy?
por: Pathak, Leilani, et al.
Publicado: (2021)

Modelling DMD-associated cardiomyopathy in patient-derived iPSCs
Publicado: (2015)

Locally expressed IGF1 propeptide improves mouse heart function in induced dilated cardiomyopathy by blocking myocardial fibrosis and SRF-dependent CTGF induction
por: Touvron, Melissa, et al.
Publicado: (2012)

Antifibrotic Effects of Roscovitine in Normal and Scleroderma Fibroblasts
por: Steinman, Richard A., et al.
Publicado: (2012)

Antifibrotic and Regenerative Effects of Treamid in Pulmonary Fibrosis
por: Skurikhin, Evgenii, et al.
Publicado: (2020)

Deciphering the Antifibrotic Property of Metformin
por: Septembre-Malaterre, Axelle, et al.
Publicado: (2022)

OPA1, a molecular regulator of dilated cardiomyopathy
por: Chen, Jiaqi, et al.
Publicado: (2023)

Genotype‐specific pathogenic effects in human dilated cardiomyopathy
por: Bollen, Ilse A. E., et al.
Publicado: (2017)

Histopathologic features of alcoholic cardiomyopathy compared with idiopathic dilated cardiomyopathy
por: Li, Xuebiao, et al.
Publicado: (2018)

Dilated cardiomyopathy following trastuzumab chemotherapy
por: Karmakar, Saurabh, et al.
Publicado: (2012)

Drug Therapy in Dilated Cardiomyopathy and Myocarditis
por: Barron, Hal
Publicado: (1989)

Reversible dilated cardiomyopathy caused by hypothyroidism
por: Khochtali, I, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_hvm192sj72tg19rnlmcde38oap